Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs ...

SAN DIEGO, CA, UNITED STATES, May 20, 2026 /EINPresswire.com/ -- Key Takeaways 1.WuXi AppTec's integrated CRDMO ...

Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

Key market opportunities in the Global Small Molecule API CDMO sector include the rising demand for complex and highly potent ...

Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the ...

High-speed industrial particle size reduction is essential for controlling particle distribution, enhancing dissolution rates ...

The CDMO market is poised for growth due to rising R&D spending, increased demand for generics and biologics, patent expirations, technological integration, and strategic partnerships. Opportunities ...

Global High Potency API CDMOs Market OverviewThe global high potency active pharmaceutical ingredient (HPAPI) CDMOs market is ...

Raw material verification is slowing pharmaceutical production, but mass spectrometry can offer a viable solution.

Procurement frameworks now incorporate resilience criteria, enabling tender preference for diversified, Europe-based manufacturing and contingency capacity over lowest price, reshaping economics for ...

When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.

Will house process development and analytical services for advanced peptide API production from development through ...